Optimizing Next Generation Sequencing for Sensitive Detection of Viral Adventitious Agents in Biologics
An Integrated Platform for Fully Automated, Continuous, & Real-Time Multi-Attributes Monitoring of Upstream Processes for Glycosylated Monoclonal Antibodies Production
Establishing Testbeds for Biopharmaceutical Manufacturing Workforce Development in Louisiana, North Carolina, Maryland, Delaware, and Texas
Evaluation of next generation sequencing (NGS) as a rapid, alternative assay for in vivo and in vitro adventitious virus testing for vaccine safety
Identification, Characterization and Removal of Host-Cell Proteins (HCP) in Chinese Hamster Ovary (CHO) Monoclonal Antibody Biomanufacturing Processes